Sarcoma and Solid Tumor Program
Joanne Lagmay, MD
Lauren Staley, ARNP
Phone: (352) 273-9120
Fax: (352) 265-4442
P.O. Box 100298
Gainesville, FL 32610
The UF Pediatric Sarcoma Program is dedicated to providing comprehensive, cutting edge and compassionate care for children and young adults who have been diagnosed with bone or soft tissue cancers and other solid tumors. We treat sarcomas such as osteosarcoma, Ewings sarcoma, rhabdomyosarcoma, synovial sarcoma and many others. Treatment for solid tumors such as neuroblastoma, Wilms tumor, hepatoblastoma, germ cell tumors and other rare tumors like nasopharyngeal carcinoma, melanoma and adrenocortical carcinoma, is also offered here. Patients with sarcoma and solid tumors often require a combination of chemotherapy, radiation and surgery for treatment. To provide multidisciplinary care requires that each patient case is discussed with many experts available within UF and Shands Cancer Center.
Members of our team include physicians from Pediatric Oncology, Orthopaedic Oncology, Medical Oncology, Pediatric Surgery , Cardiothoracic Surgery, Musculoskeletal Radiology, Radiation Oncology, Reproductive Fertility and Musculoskeletal Pathology, as well as specialists in nursing, clinical pharmacy, social work, psychology, physical therapy and nutrition. Together, we develop an individualized treatment plan for each patient. The program collaborates closely with the University of Florida Proton Therapy Institute, one of nine centers in the country. Dr. Joanne Lagmay, pediatric oncologist, collaborates with members of the Departments of Veterinary Medicine, Radiological Engineering, Chemistry, Materials Science and Radiation Oncology, in the development of polymer‐mediated radionuclide therapies in a canine model for targeting osteosarcoma. Furthermore, the NIH RO1 funded Musculoskeletal Oncology Laboratory headed by orthopedic oncologist Dr. Charles Parker Gibbs focuses on the molecular differences of the cells within individual patients’ tumors, identifying key cellular pathways responsible for tumor initiation in osteosarcoma. His lab is developing novel methods to induce reversal of the malignant character of cells in a patient’s tumor.
Through local and national partnerships, the Pediatric Sarcoma Program has been successful in enrolling patients on novel clinical trials. Such participation in clinical research efforts allow us to provide patients and families with access to both expert, state-of-the-art care, as well as clinical trial options.
- Veterinary Medicine Osteosarcoma
- Orthopaedic Oncology
- Radiation Oncology
- UF Proton Therapy Institute